An interventional study of FES therapy and TECAR therapy and FES in Neuro: Cerebrovascular Accident, sponsored by October 6 University. Completed at 1 site in Jordan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-22.
Sponsored by October 6 University · Not applicable, Interventional, and Treatment
Upper-limb spasticity and impaired hand function are experienced by up to 70% of stroke survivors, which significantly restricts their independence in fulfilling daily activities. This research aims to assess whether combining TECAR therapy with FES produces superior improvements in hand function compared to FES alone in stroke patients with upper-limb spasticity.
Even though both FES and TECAR therapy have been demonstrated to be effective on their own, no studies have investigated the potential synergistic effects of combining these modalities for upper limb rehabilitation in stroke patients. FES addresses the neurological component of motor impairment by promoting neuroplasticity and facilitating functional movements. TECAR, in contrast, targets the biomechanical component by improving tissue viscoelasticity, decreasing spasticity, and increasing blood flow to afflicted muscles and tendons. The justification for combining these therapies is quite compelling. It is possible that this combination could alleviate post-stroke motor impairment by addressing both neural and peripheral components.
So, this research aimed to assess whether the combination of TECAR therapy and FES produces superior improvements in hand function, spasticity reduction, and functional independence compared to FES alone in chronic stroke survivors with upper limb spasticity and flexor synergy.
October 6 University is the lead sponsor of 142 studies on the registry; 28 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
administrated FES therapy in addition to standard rehabilitation
Device: FES therapy
received a combination of TECAR therapy and FES in addition to standard rehabilitation
Device: FES therapy · Device: TECAR therapy and FES
FES device (MegaXP FES Machine, South Korea). Two bipolar surface electrodes (active and indifferent, diameter 1.5 inches) were placed over the wrist and finger extensors: Extensor Carpi Radialis Longus (ECRL), Extensor Carpi Radialis Brevis (ECRB), and Extensor Digitorum Communis (EDC). Electrodes were positioned to achieve balanced wrist extension without excessive radial or ulnar deviation.
The protocol started with TECAR in the resistive mode (110-140 W, 5 minutes) on the wrist and finger extensor muscles with slow, circular movements combined with functional massage. We continued with TECAR in the capacitive mode in the same region (180-200 VA, 4 minutes) with gentle gliding movements. We ended the TECAR session with the resistive mode on the dorsal hand, wrist joint, and finger extensor tendons (100-120 W, 3 minutes) with focal application on specific tendinous and joint structures
The Modified Ashworth Scale
a 6-point clinical tool used to measure increased muscle tone (hypertonia) and resistance to passive movement in patients with central nervous system conditions. Scoring: grade 0 (normal), grade 1 and 1+ (mild spasticity), grade 2 and 3 (moderate spasticity), grade 4 (severe spasticity)
Time frame: one month
Action Research Arm Test
a 19-item observational measure used by clinicians to evaluate upper-extremity coordination, dexterity, and functional performance in patients with neurological conditions such as stroke, traumatic brain injury (TBI), or multiple sclerosis. A 4-point rating system is used to evaluate task performance, with 0 representing no movement and 3 representing normal movement
Time frame: one month
The upper extremity Fugl-Meyer Assessment
A 3-point ordinal scale, with 0 representing "cannot perform," 1 representing "performs partially," and 2 representing "performs fully," is used to rate scale items based on the ability to complete them. 226 is the maximum possible score on the scale.
Time frame: one month
Functional Independence Measure (FIM) self-care component
Self-care independence, sphincter control, transfers, mobility, communication, and social cognition are all evaluated. The degree of assistance needed determines the functional status, which ranges from entire assistance to complete independence. Higher scores indicate greater independence. The total score falls between 18 and 126.
Time frame: one month
Surface electromyography (sEMG)
a safe, non-invasive technique that records the electrical activity of skeletal muscles using electrodes placed directly on the skin. Measurements: evaluate activation of extensor carpi radialis (ECR) and extensor digitorum communis (EDC).
Time frame: one month
Ran from Jun 2026 to primary completion in Jul 2026, 1 month.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.